NORTHERN TRUST CORP - NEUBASE THERAPEUTICS INC ownership

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 48 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,161
-2.7%
54,9260.0%0.00%
Q4 2022$10,447
-52.5%
54,9260.0%0.00%
Q3 2022$22,000
-62.1%
54,9260.0%0.00%
Q2 2022$58,000
-43.7%
54,9260.0%0.00%
Q1 2022$103,000
-33.1%
54,9260.0%0.00%
Q4 2021$154,000
-22.2%
54,9260.0%0.00%
Q3 2021$198,000
-24.7%
54,9260.0%0.00%
Q2 2021$263,000
-80.5%
54,926
-69.9%
0.00%
Q1 2021$1,347,000
-2.8%
182,286
-8.1%
0.00%
Q4 2020$1,386,000
-6.2%
198,246
+1.8%
0.00%
Q3 2020$1,478,000
-13.2%
194,749
+0.4%
0.00%
Q2 2020$1,703,000193,9970.00%
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CARNEGIE MELLON UNIVERSITY 46,970$40,8550.05%
View complete list of NEUBASE THERAPEUTICS INC shareholders